about
Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humansChinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)Respiratory viruses other than influenza virus: impact and therapeutic advancesDevelopment of Medical Countermeasures to Middle East Respiratory Syndrome CoronavirusCritically ill patients with Middle East respiratory syndrome coronavirus infectionAntiviral Treatment Guidelines for Middle East Respiratory SyndromeThe effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysisA new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoModernising epidemic science: enabling patient-centred research during epidemicsWhat is the optimal therapy for patients with H5N1 influenza?Structure and inhibition of the SARS coronavirus envelope protein ion channelCoronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeuticsThe severe acute respiratory syndrome epidemic in mainland China dissected.A review of treatment modalities for Middle East Respiratory Syndrome.Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemicFeasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.Advances in antivirals for non-influenza respiratory virus infections.Avian influenza virus, Streptococcus suis serotype 2, severe acute respiratory syndrome-coronavirus and beyond: molecular epidemiology, ecology and the situation in China.Neurological Complications of Middle East Respiratory Syndrome Coronavirus: A Report of Two Cases and Review of the Literature.A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan.Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technologyCoronaviruses post-SARS: update on replication and pathogenesis.Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture.Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaquesThe emergence of the Middle East respiratory syndrome coronavirusThe management of coronavirus infections with particular reference to SARS.Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelityCoronaviruses: an overview of their replication and pathogenesis.A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challengePassive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infectionToll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus InfectionDrosophila as a genetic model for studying pathogenic human virusesRespiratory Infections in the U.S. Military: Recent Experience and ControlInterferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome.Cyclosporin A inhibits the replication of diverse coronavirusesFeasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians.Effective inhibition of MERS-CoV infection by resveratrol
P2860
Q22255463-E75D6FE0-4546-4986-925E-29B29CBAE38EQ24198854-201CCE04-9F2A-4AF3-82EC-C2CA7BF62DCDQ24244611-667742B9-E438-43A2-8129-3835FD0831B0Q24655957-30420B9A-E5B3-498E-BDCE-00E0829F465AQ26700054-D58E2B86-CD35-4D78-917A-8B6B1C6BEAA5Q26764948-144C6D18-29CC-4C4A-9CED-EE898A4C2AEEQ26781374-7CFDD75B-7E46-49A0-9BE8-EC55AA0C0504Q27001157-D0CF35A9-E95E-4BC7-B6C3-6E590F427A9FQ27490484-D9B96A5E-740E-4784-9F61-6AD5043E9887Q28119742-E788BA92-0D19-4323-B5BF-302927DAF19AQ28475630-D0B759B8-BD35-41CD-A838-C7C8250C606CQ28475712-EC64912D-3CB6-40B1-B849-F95E93C66F18Q28535361-098B7E8D-F2D5-48F5-BC68-F2A1DE4E5407Q30226703-C9FD01CF-5672-4695-9B2F-43FDE5B080FEQ30248209-5F255356-6AD1-47F1-8CEA-DA4A7119F1FEQ30352743-91EDC577-6808-47FF-86BF-936FBB477416Q30356651-927968F8-7729-4D77-B317-7B136C0994B0Q30457132-FA849CEA-03DC-4A5E-8F15-252CDE92BEDFQ31080225-0F48674B-A22E-4BAA-9E53-3B2223632866Q33432598-BBC14F88-3C54-4D58-BCFE-2C8A4FF1F1ECQ33537455-F6B89214-88E6-4B8A-9067-AEEFCE5CD3B5Q33591243-3911E175-7911-4BED-9BAD-A4CFEB446EAEQ33688229-B3205B44-857E-4C24-8A95-D583C619C632Q33694361-5F63E44C-A44A-4248-A125-3610D9AF242DQ33747584-14561B72-C5A6-479A-AC3D-8FA2A072371AQ33887877-7D2D3631-D1A4-4B11-90B1-C0E1F74DB8FBQ33934034-F211E98B-1C00-4A7A-86E2-2770A4A4D2A8Q34012358-5376FEF5-90F9-40A4-B7D2-3FD3BA71C7EFQ34058365-13A632CE-F555-41A2-ADA9-08A2FB8FDBB6Q34392620-BE0F0533-4449-45E1-B91B-A59E624352EEQ34464697-D628FB3B-52AB-4812-93CF-B6C2304CCD71Q35531454-8FBA1FF6-B1BD-4A5C-AF98-A3633DB3A55EQ35641110-D180CC6A-6818-4C06-BF99-F85C36334383Q35660187-A076ADC4-213E-4C93-AE5C-FC2AED7F25F9Q35661115-84E8CC41-63FC-4E10-900B-0D917D8B3E4AQ35763405-F5A53E6B-A2CD-46EA-ADDD-9D18B12C109BQ35947818-DF704600-8625-44F8-A51E-E6ABB4DA9025Q35960586-F39D43A8-B57C-4E19-A760-308849A7850FQ36074163-63929B41-AEC7-4252-B4D5-178390BBFF43Q36279084-770E8576-4B90-4103-ABD3-A08B7134BDB4
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
SARS: systematic review of treatment effects
@ast
SARS: systematic review of treatment effects
@en
SARS: systematic review of treatment effects
@en-gb
SARS: systematic review of treatment effects
@nl
type
label
SARS: systematic review of treatment effects
@ast
SARS: systematic review of treatment effects
@en
SARS: systematic review of treatment effects
@en-gb
SARS: systematic review of treatment effects
@nl
prefLabel
SARS: systematic review of treatment effects
@ast
SARS: systematic review of treatment effects
@en
SARS: systematic review of treatment effects
@en-gb
SARS: systematic review of treatment effects
@nl
P2860
P31
P921
P3181
P1433
P1476
SARS: systematic review of treatment effects
@en
P2093
Lauren J Stockman
Richard Bellamy
P275
P2860
P3181
P356
10.1371/JOURNAL.PMED.0030343
P407
P50
P5008
P577
2006-09-01T00:00:00Z